Market
Axogen deepens nerve repair portfolio through $200m BioCircuit takeover
Axogen acquired BioCircuit Technologies for $200 million to expand its peripheral nerve repair portfolio, adding NerveTape, a sutureless nerve repair device, to its product line. The deal aims to accelerate market adoption of the technology and strengthen Axogen's position in the nerve repair sector.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network